Ongoing randomized Phase III studies of supportive care in adult acute lymphoblastic leukemia (ALL).
| Study group . | Study name . | Age range, y . | Main study questions/aims . |
|---|---|---|---|
| MDACC | ID01-592 | No age restrictions | Erythropoetin versus supportive care (all types receiving hyper-CVAD or augmented BFM regimens). |
| MDACC | ID03-0124 | ≥ 18 | Atonal vs. placebo for prevention of bone loss during hyper-CVAD |
| MDACC | 2004-0107 | ≥ 15 | Tight control of glucose during hyper-CVAD. |
| GMALL | GMALL08 | ≥ 15 | Rasburicase vs. allopurinol during induction. |
| Study group . | Study name . | Age range, y . | Main study questions/aims . |
|---|---|---|---|
| MDACC | ID01-592 | No age restrictions | Erythropoetin versus supportive care (all types receiving hyper-CVAD or augmented BFM regimens). |
| MDACC | ID03-0124 | ≥ 18 | Atonal vs. placebo for prevention of bone loss during hyper-CVAD |
| MDACC | 2004-0107 | ≥ 15 | Tight control of glucose during hyper-CVAD. |
| GMALL | GMALL08 | ≥ 15 | Rasburicase vs. allopurinol during induction. |